Capital Fund Management »

Adaptive Biotechnologies Cor shares owned by Capital Fund Management

Quarter-by-quarter ownership of Adaptive Biotechnologies Cor (ADPT) shares owned by Capital Fund Management from 13F filings

Historical chart of Capital Fund Management investment in Adaptive Biotechnologies Cor

Tip: Access up to 7 years of quarterly data

All positions including Adaptive Biotechnologies Cor held by Capital Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptive Biotechnologies Cor by Capital Fund Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $479k 35k 13.88

More positions owned by Capital Fund Management

Tesla Tesla Inc Com (TSLA)
Micron Technology Micron Technology Inc Com (MU)
Apple Apple Inc Com (AAPL)
Microsoft Corp Microsoft Corp Com (MSFT)
Taiwan Semiconductor Manufac Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Chevron Corporation Chevron Corporation Com (CVX)
Amazon Amazon Com Inc Com (AMZN)
Eli Lilly & Co Eli Lilly & Co Com (LLY)
Palantir Technologies Inc Cl A Palantir Technologies Inc Cl A (PLTR)
Citigroup Citigroup Inc Com New (C)
Berkshire Hathaway Inc Del Cl B Berkshire Hathaway Inc Del Cl B New (BRK.B)
Ge Aerospace Ge Aerospace Com New (GE)
Meta Platforms Inc Cl A Meta Platforms Inc Cl A (META)
Advanced Micro Devices Advanced Micro Devices Inc Com (AMD)
Lam Research Corp Lam Research Corp Com New (LRCX)

View all positions for Capital Fund Management

Top funds holding Adaptive Biotechnologies Cor

Viking Global Investors
BlackRock
Vanguard Capital Management
Westfield Capital Management Company
Vanguard Portfolio Management
Invesco
Wellington Management Company
Geode Capital Management
Lord, Abbett & Co
Goldman Sachs Group
State Street Corporation
Ameriprise Financial
Bnp Paribas Investment Partners
ARK Investment Management
Fred Alger Management

View all funds holding Adaptive Biotechnologies Cor